The Reserpine,hydralazine Hydrochlor, cataloged under National Stock Number 6505-00-899-9496, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Ciba-Geigy Corp Ciba Pharmaceuticals Div. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-00-899-9496 |
| Primary Part Number | NDC00083-0071-30 |
| Item Name | Reserpine,hydralazine Hydrochlor |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Ciba-Geigy Corp Ciba Pharmaceuticals Div |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 25.000 MILLIGRAMS HYDRALAZINE HYDROCHLORIDE ACTIVE INGREDIENT AND 15.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT AND 0.100 MILLIGRAMS RESERPINE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00083-0071-30 PRIMARY | Ciba-Geigy Corp Ciba Pharmaceuticals Div (USA) |
| Reference | Meaning |
|---|---|
| F0083007130 | 5/1 Secondary reference U.S. Government activity |
| SER-AP-ES | 5/1 Secondary reference Ciba-Geigy Corp Ciba Pharmaceuticals Div |
NSN 6505-00-899-9496 is a Reserpine,hydralazine Hydrochlor, manufactured by Ciba-Geigy Corp Ciba Pharmaceuticals Div, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-899-9496 has 1 manufacturer part number on file: NDC00083-0071-30 (Ciba-Geigy Corp Ciba Pharmaceuticals Div).
Key specifications for NDC00083-0071-30: Primary Container Content Quantity: 100.000 TABLETS; Primary Container Type: BOTTLE; Active Medicament Medicinal Strength: 25.000 MILLIGRAMS HYDRALAZINE HYDROCHLORIDE ACTIVE INGREDIENT AND 15.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT AND 0.100 MILLIGRAMS RESERPINE ACTIVE INGREDIENT. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.